FDA Requires New Eye-Risk Warnings on GLP-1 Drugs
The agency is calling for labels to flag a possible link to a rare eye condition, though a causal relationship has not been established.
Makkler Newsroom · Nov 10, 02:58 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $1,501.06 (+4.0%)
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO